Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
BVI Medical’s FineVision HP Trifocal IOL Gains US FDA Approval
BVI Medical announced Oct. 14 that the US FDA had approved its FineVision HP trifocal intraocular lens (IOL). The company said the lens, the world’s first trifocal IOL, was backed by 15 years of cl...
Optos Launches the Silverstone RGB Advanced Retinal Imaging System
UK-based Optos announced Oct. 15 that it had launched its next-generation Silverstone RGB system for retinal imaging. The device is designed to allowclinicians to capture, visualize, and analyze pa...
Iantrek Announces US Commercial Launch of AlloFlo Uveo Biostent for Glaucoma
Iantrek announced Oct. 14 the US commercial launch of the AlloFlo Uveo, a novel minimally invasive glaucoma surgical (MIGS) device targeting the uveoscleral drainage pathway. The AlloFlo Uveo allog...
EssilorLuxottica Acquires Screening Software Company RetinAI
Eyewear conglomerate EssilorLuxottica announced Oct. 15 that it would acquire Swiss company Ikerian, operating under the RetinAI brand. RetinAI develops tools to collect, process, and grade large-s...
Epion Therapeutics Forms Strategic Partnership with Oculus
Epion Therapeutics announced Oct. 7 that it had entered a strategic partnership with Germany’s Oculus, maker of the Pentacam corneal topographer. The partnership comes in conjunction with Epion clo...
Biotech Healthcare Launches Optiflex Xtense Comfort Plus EDOF IOL in Europe
Biotech Healthcare announced Sept. 23 that it had launched the Optiflex Xtense Comfort Plus extended-depth-of-focus (EDOF) intraocular lens at the ESCRS 2025 congress in Copenhagen, Denmark. Biotec...
OcuSciences’ OcuMet Beacon Retinal Imager Gains CE Marking
OcuSciences, of Ann Arbor, Michigan, announced Oct. 15 that its OcuMet Beacon retinal imager had gained CE marking under the European Medical Device Regulation. The device gained US FDA 510(k) clea...
Konan Medical’s ObjectiveField Perimeter Gains CE Marking
Konan Medical announced Oct. 10 that its ObjectiveField visual field analyzer had gained CE marking under the European Medical Device Regulation. The ObjectiveField is an objective perimeter design...
US FDA Approves Celltrion’s Aflibercept Biosimilar Branded Eydenzelt
South Korea’s Celltrion announced Oct. 9 that the US FDA had approved Eydenzelt, an aflibercept (Eylea) biosimilar. Eydenzelt (aflibercept-boav 40 mg/mL solution for injection) is indicated for wet...
US FDA Gives Green Light to Trial of Avisi’s VisiPlate Aqueous Shunt for Glaucoma
Avisi Technologies announced Oct. 14 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a trial of the VisiPlate aqueous s...
RetinalGenix Partners with Genotyping Lab on Disease Detection Through the Eye
RetinalGenix Technologies announced Oct. 1 that it would collaborate with genotyping lab RGEN, of West Virginia, to advance the early detection of neurodegenerative, systemic, and retinal diseases....
Ashvattha Names Bob Dempsey as Interim CEO
Ashvattha Therapeutics, of Redwood City, California, announced Oct. 14 that it had appointed Robert J. Dempsey as interim chief executive officer. The move follows the company’s release of positive...
Past News Stories
Nova Eye’s iTrack Advance Canaloplasty Device Approved in China
Australia’s Nova Eye Medical announced Sept. 30 that China’s National Medical Products Administration had approved the marketing of the company’s iTrack Advance canaloplasty device for glaucoma. Th...
US Senator to Review AMA’s Fee Structure to Use its CPT Code Set
US Senator Bill Cassidy, MD, R-Louisiana, has opened a review into the American Medical Association (AMA), claiming it charges “exorbitant fees” for use of its CPT code set. The code set is created...
Teresa Puthussery, PhD, OD, Named 2025 MacArthur Fellow
Teresa Puthussery, PhD, a neurobiologist and optometrist, has been named one of the 22 MacArthur Fellows for 2025. The MacArthur Foundation, based in Chicago, Illinois, annually selects fellows who...
Oculis Accelerates Privosegtor Toward Pivotal Trials in Neuro-ophthalmology
Swiss company Oculis announced Oct. 6 that it will advance Privosegtor into a pivotal program for two indications in neuro-ophthalmology following a positive meeting with the US FDA. Privosegtor is...
Rayner Gains US FDA Approval of RayOne EMV Toric IOL
UK-based Rayner announced Oct. 13 that the US FDA had approved its RayOne EMV Toric intraocular lens (IOL), and the lens is now available. Rayner CEO Tim Clover said: “The long-awaited FDA approval...
Generic Drugmakers with US Sources Now Eligible for FDA Priority Review
The US FDA reported Oct. 3 that a new pilot program would speed the approval process for some generic drugmakers: They would be eligible for priority review if they conducted any required bioequiva...
Regulators in China Accept BLA for DME Candidate from Santen, RemeGen
Japan’s Santen Pharmaceutical and partner RemeGen announced Sept. 30 that China’s Center for Drug Evaluation had accepted the biologic license application (BLA) for retinal treatment candidate RC28...
US FDA Gives Green Light to Phase I/II Trial of Complement’s GA Gene Therapy Candidate
Complement Therapeutics announced Oct. 8 that the US FDA had signed off on its investigational new drug (IND) application, allowing the company to proceed with a Phase I/II trial of CTx001, a gene ...
Vivani Delays Record Date for Cortigent Spinoff Due to Shutdown
Vivani Medical, of Alameda, California, reported Oct. 3 that it has temporarily withdrawn the record date for spinning off its Cortigent subsidiary due to delays arising from the current shutdown o...
Harrow Names Frank Mullery as CEO of ImprimisRx Subsidiary
Harrow, of Nashville, Tennessee, announced Oct. 6 that Frank Mullery had been appointed chief executive officer of its ImprimisRx ophthalmic compounding subsidiary. Harrow said Mullery is a senior ...
Myopia Lenses from EssilorLuxottica Gain US FDA De Novo Marketing Authorization
Eyewear giant EssilorLuxottica and the US FDA announced Sept. 25 that the company’s Stellest spectacle lenses had gained de novo marketing authorization to slow the progression of myopia in childre...
Harrow to Expand Access for All Program to Full Drug Portfolio
Harrow, of Nashville, Tennessee, reported Sept. 25 that it was expanding its Vevye Access for All program to the rest of its portfolio, making it easier and more affordable for patients to obtain t...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.